baber/WOPTO huggingface dataset:
Patent DE-610897-T1 (DE)
Inventor: MARUYAMA NOBORU
IPC: F28D1/06
Filed: 1994-02-08
Abstract: The heat absorbing member formed by connecting to the bottom portion of the inlet header (1) with that of the outlet header (2) through the heat absorbing tube is installed so that the heat absorbing tube is located in the heating container (9), the heat absorbing tube (16) is comprised of a plurality of the down tubes (3, 4) and down tubes (5, 6) all with lower ends closed and connected under the inlet header (1) and outlet header (2) respectively, and the spiral tubes (7, 8) which connect to the top with the bottom portion of the down tubes (3, 4) and down tubes (5, 6), and the spiral tubes (7, 8) are the same length. <IMAGE>
Patent DE-1112231-T1 (DE)
Inventor: VIRLOGET FRANCOIS
IPC: C02F11/16
Filed: 1999-08-11
Abstract: The invention concerns a method for treating effluents in small communities, that is communities consisting of about 200 to 2000 inh.eq (inhabitant equivalent), characterised in that it consists in: carrying out a biological treatment of the effluent using a trickling filter eliminating matters suspended in the treated effluent, and, simultaneously performing a treatment of the sludge by filtering-composting on filters planted with reeds.
Patent ES-2224917-T1 (ES)
Inventor: KENDRICK BRENT S
IPC: A61K38/48
Filed: 2000-09-29
Abstract: Frozen and lyophilized compositions for a metalloproteinase fibrinolytic agent (fibrolase or NAT), a method for preparing the lyophilized composition, and a kit and method for reconstituting the lyophilized composition are described herein.
Patent ES-2233227-T1 (ES)
Title: Procedimiento para la preparacion de ingredientes farmaceuticos activos con un area superficial especifica.
Inventor: SAMBURSKI GUY
IPC: A61K9/14
Filed: 2004-03-25
Abstract: Procedimiento para la preparación de un ingrediente farmacéutico activo que presenta un área superficial específica de por lo menos 5,0 m2/g aproximadamente, según medición efectuada mediante el procedimiento B.E.T., que comprende: a) almacenar el ingrediente farmacéutico activo a una temperatura inferior a 0ºC aproximadamente; y b) micronizar el ingrediente farmacéutico activo con el fin de obtener un área superficial específica de por lo menos 5,0 m2/g aproximadamente.
Patent ES-2564577-T1 (ES)
Title: Aparato de cascada de agua iluminado
Inventor: VOGTNER ZACHARY
IPC: F21S10/02
Filed: 2013-10-21
Abstract: Un aparato de cascada de agua para producir una cascada de agua artificial que comprende: a) una ranura de cascada de agua para producir una cascada de agua; b) una unidad de iluminación; c) una cámara para contener la unidad de iluminación, en donde la cámara es proximal a la cascada de agua y en donde la cámara tiene al menos un lado que es un material que permite que la luz de la unidad de iluminación actúe sobre la cascada de agua; y d) un puerto a la cámara para acceder a la unidad de iluminación.
Patent ES-2033664-T1 (ES)
Title: Procedimiento de regulacion de un dispositivo de depuracion de aguas residuales.
IPC: C02F11/04
Filed: 1992-01-28
Abstract: PROCESO DE REGULACION Y DE CONDUCCION AUTOMATICA DE UN DISPOSITIVO DE DESCONTAMINACION DE AGUAS RESIDUALES POR FERMENTACION METANICA, CARACTERIZADO EN QUE CONSISTE EN MEDIR SIMULTANEAMENTE, EN LA FASE GASEOSA DE LOS DIGESTORES (6) DE UN REACTOR DE FERMENTACION (10) LOS SIGUIENTES TRES PARAMETROS: EL CAUDAL DE GAS OBTENIDO (12) DE LA TRANSFORMACION DEL MATERIAL ORGANICO DURANTE LA FERMENTACION, LA RELACION DE LOS PORCENTAJES DE METANO Y DE GAS CARBONICO (14) Y EL CONTENIDO DE HIDROGENO GASEOSO (16), Y DESPUES EN TRATAR EN TIEMPO REAL LAS INFORMACIONES ASI RECOGIDAS (18) PARA OBTENER SEÑALES QUE TRADUCEN EL ESTADO INSTANTANEO DEL ECOSISTEMA DEL DISPOSITIVO DE DESCONTAMINACION.
Patent ES-2106000-T1 (ES)
Inventor: SCHAEFER STEFAN
IPC: B60N3/10
Filed: 1996-12-13
Abstract: The drink container holder has a first element (1) which is in the form of a support, and which is fastened to a second element (2) which is in the form of a slider. The assembled elements can be inserted into, and removed from, a third element (3) which forms a housing. A lever (20), or a rocker arm (21), or a disc (22) with cams is either fixed to the third element, or is mounted on the latter so that it can rotate. Each lever or cam engages in the rocker arm and has a pivoting region which is limited in order to fit an opening in the rocker arm. A spring (23) is fastened to the third element, in order to cause a partial or complete extension of the assembled first and second elements.
Patent ES-2161662-T1 (ES)
Title: Metodo y composiciones para decorar vidrio.
Inventor: KAMEN MELVIN E
IPC: C09D11/10
Filed: 1998-05-22
Abstract: Un método para decorar un artículo vítreo, que comprende las operaciones de: a) aplicar al artículo vítreo, en un diseño predeterminado, una composición de tinta curable por radiación que es (i) susceptible cuando está curada de unirse al artículo vítreo, y (ii) separable del artículo vítreo por exposición a un álcali; y b) curar la tinta sobre el artículo vítreo exponiéndola a la radiación mediante la cual es curable, con lo cual la tinta se une al artículo vítreo.
Patent CY-1108292-T1 (CY)
Title: Αντικαρκινικο σκευασμα που περιεχει dmxaa
Inventor: BAGULEY BRUCE CHARLES
IPC: A61P35/00
Filed: 2008-08-25
Abstract: Η παρούσα εφεύρεση σχετίζεται με τη χρήση ενώσεων όπως ενώσεων της τάξης του ξανθενονοξεικού οξέος όπως 5,6-διμεθυλοξανθενον-4-οξεικό οξύ (DMXAA) για τη θεραπεία του καρκίνου, όπου οι ενώσεις χορηγούνται γαστρεντερικώς, κατά προτίμηση από το στόμα. Ειδικότερα, η εφεύρεση ασχολείται με τη χρήση τέτοιων ενώσεων, όπου η ένωση μεταφέρεται στη θέση δράσης στον ασθενή που πρόκειται να δεχθεί τη θεραπεία σε δύο ή περισσότερες δόσεις.
Patent CY-1108307-T1 (CY)
Inventor: FATTOM ALI IBRAHIM
IPC: A61K39/09
Filed: 2008-09-02
Abstract: The invention concerns an isolated  Enterococcus faecium  antigen comprising 2-acetamido-2-deoxy-galactose and galactose, in particular one which reacts with antibodies to ATCC 202015. Furthermore an antigen-carrier conjugate comprising the antigen bonded to an immunocarrier; a composition comprising such an antigen and a carrier; and an immune globulin containing antibodies directed against such antigens and a carrier.
Patent CY-1109452-T1 (CY)
Title: Μεταλλαγμενες παραλλαγες ινσουλινικου αυξητικου παραγοντα (igf)i
Inventor: DUBAQUIE YVES
IPC: A61P5/44
Filed: 2009-10-02
Abstract: Παρέχονται παραλλαγές IGF-I και ινσουλίνης που δεσμεύονται επιλεκτικά με IGFBP-1 και IGFBP-3. Αυτές οι αγωνιστικές παραλλαγές είναι χρήσιμες, για παράδειγμα, σε βελτίωση των ημιζωών του IGF-I και της ινσουλίνης, αντίστοιχα.
Patent CY-1113724-T1 (CY)
Title: Φαρμακευτικη συνθεση για την θεραπεια διαταραχων γαστρεντερικου ερεθισμου
Inventor: BELLINVIA SALVATORE
IPC: A61K33/08
Filed: 2013-02-27
Abstract: Η εφεύρεση σχετίζεται με μία φαρμακευτική σύνθεση που βασίζεται σε μια δραστική ουσία, όπως κυρίως η Σουκραλφάτη, για τη θεραπεία διαταραχών που σχετίζονται με γαστρεντερικό ερεθισμό, όπως γαστρικά έλκη, δωδεκαδακτυλικά έλκη, οξεία γαστρίτιδα, συμπτωματική χρόνια γαστρίτιδα, γαστροπάθεια που σχετίζεται με αντιφλεγμονώδη, οισοφαγίτιδα εκ παλινδρόμησης, που χαρακτηρίζεται στο ότι περιλαμβάνει ένα ή περισσότερα φωσφολιπίδια. Η εφεύρεση σχετίζεται με τη χρήση των φωσφολιπιδίων σε συνδυασμό με την εν λόγω δραστική ουσία που πρόκειται να χορηγηθεί δια του στόματος για τη βελτίωση της γευστικότητάς της και με τη χρήση των φωσφολιπιδίων σε συνδυασμό με την εν λόγω δραστική ουσία που πρόκειται να χορηγηθεί δια του στόματος για τη θεραπεία διαταραχών γαστρεντερικού ερεθισμού και για να βελτιώσει συνεργιστικά την αντί-ελκωτική επίδραση της.
Patent CY-1114349-T1 (CY)
Title: Συμπυκνωμενα παραγωγα ιμιδαζολης για την αναστολη της συνθασης της αλδοστερονης και της αρωματασης
Inventor: KSANDER GARY MICHAEL
IPC: C07D487/04
Filed: 2013-07-02
Abstract: H παρούσα εφεύρεση παρέχει μία ένωση με τον τύπο (Ι). Η εν λόγω ένωση είναι ένας αναστολέας της συνθάσης της αλδοστερόνης και της αρωματάσης, και επομένως είναι δυνατό να χρησιμοποιηθεί για τη θεραπευτική αντιμετώπιση μίας διαταραχής ή μίας νόσου στην οποία διαμεσολαβεί η συνθάση της αλδοστερόνης ή η αρωματάση. Συνεπώς η ένωση με τον τύπο Ι είναι δυνατό να χρησιμοποιηθεί για τη θεραπευτική αντιμετώπιση της υποκαλιαιμίας, της υπέρτασης, της συμφορητικής καρδιακής ανεπάρκειας, της κολπικής μαρμαρυγής, της νεφρικής ανεπάρκειας, ιδιαίτερα, της χρόνιας νεφρικής ανεπάρκειας, της επαναστένωσης, της αθηρωσκλήρυνσης, του συνδρόμου Χ, της παχυσαρκίας, της νεφροπάθειας, μετά από έμφραγμα του μυοκαρδίου, της στεφανιαίας νόσου, της φλεγμονής, του αυξημένου σχηματισμού κολλαγόνου, της ίνωση όπως η ίνωση της καρδιάς ή του μυοκαρδίου, της αναδιαμόρφωσης μετά από υπέρταση και δυσλειτουργία του ενδοθηλίου, της γυναικομαστίας, της οστεοπόρωσης, του καρκίνου του προστάτη, της ενδομητρίωσης, των ινώματων της μήτρας, της δυσλειτουργικής αιμορραγίας της μήτρας, της υπερπλασίας του ενδομητρίου, του συνδρόμου των πολυκυστικών ωοθηκών, της στειρότητα, της ινωκυστικής νόσου του μαστού, του καρκίνου του μαστού και της ινωκυστικής μαστοπάθειας. Τέλος η παρούσα εφεύρεση παρέχει επίσης μία φαρμακευτική σύνθεση.
Patent CY-1115354-T1 (CY)
Title: Ενωσεις πεγκυλιωμενης ινσουλινης lispro
Inventor: BEALS JOHN MICHAEL
IPC: A61K38/28
Filed: 2014-06-26
Abstract: Η παρούσα εφεύρεση αναφέρεται στο πεδίο του διαβήτη. Ειδικότερα, η εφεύρεση αφορά σε ενώσεις πεγκυλιωμένης ινσουλίνης lispro που πεγκυλιώνονται με υψηλού μοριακού βάρους πολύ(αιθυλενογλυκόλη), είναι ιδιαίτερα διαλυτές σε φυσιολογικό pΗ, έχουν μια εκτεταμένη διάρκεια δράσης και χαρακτηρίζονται από φαρμακοκινητικούς, φαρμακοδυναμικούς, ή/και αιχμής-κοιλιάς λόγους μικρότερους από 2. Η εφεύρεση αφορά επίσης σε μεθόδους παροχής αυτών των μορίων, σε φαρμακευτικές συνθέσεις που τα περιέχουν και στις θεραπευτικές χρήσεις τους.
Patent CY-1117843-T1 (CY)
Title: Νεα παραγωγα θειενοπυριμιδινης, διεργασιες για την παρασκευη αυτων και θεραπευτικες χρησεις αυτων
Inventor: CARRY JEAN-CHRISTOPHE
IPC: C07D495/04
Filed: 2016-06-15
Abstract: Η παρούσα εφεύρεση αφορά ενώσεις του τύπου (I): όπου το R6 είναι -CONH2 ή μια -C(Rα)(Rβ)(OH) ομάδα, το R είναι μια υποκατεστημένη φαινυλ ή ετεροαρυλ ομάδα, το R7 είναι μια προαιρετικώς υποκατεστημένη αρυλ ή ετεροαρυλ ομάδα. Διεργασία για την παρασκευή αυτών και θεραπευτική χρήση αυτών.
Patent CY-1124651-T1 (CY)
Title: Αντισωμα εναντι toy her2 και συζευγμα αυτου
Inventor: FANG JIANMIN
IPC: C07K16/28
Filed: 2021-08-06
Abstract: Γνωστοποιούνται ένα αντίσωμα έναντι του HER2 και σύζευγμα του αντισώματος έναντι του HER2 και φαρμακευτικό μέσο μικρών μορίων. Επίσης, γνωστοποιούνται χρήσεις του αντισώματος και του συζεύγματος αυτού στην παρασκευή φαρμακευτικού μέσου για τη θεραπευτική αντιμετώπιση όγκου.
Patent GR-920300036-T1 (GR)
Title: Method for the detoxification of water and materials for it
Inventor: RIEDE URSUS
IPC: C02F1/52
Filed: 1992-08-26
Abstract: Surface waters contaminated with hazardous materials can be universally and effectively detoxified by addition of a material, which essentially contains low-molecular-weight alkali metal humates.
Patent GR-960300028-T1 (GR)
Title: Process of preparation of poor pesticide active principles concentrates from plants
Inventor: STEINER RUDOLF
IPC: A23L27/10
Filed: 1996-05-31
Abstract: Prepn. of low-pesticide, active ingredient concentrate of plants comprises: (a) extracting fresh or dried plants or plant parts with at least one polar solvent at pH of 3.2-9.8 so that the prim. extract contains mainly the desired plant components accompanied by undesired plant components, accompanying substances and pesticides; (b) contacting prim. extract with adsorber resin which adsorb desired plant components and leaves undesired plant components, accompanying substances and pesticides in soln.; (c) desorbing desired plant components from loaded resin using at least one solvent; (d) partially or completely removing solvent to give active ingredient concentrate (I).
Patent HR-P20100203-T1 (HR)
Title: Cured in place liner with integral inner impermeable layer and continuous method of manufacture
Inventor: DRIVER FRANKLIN THOMAS
IPC: B29C63/06
Filed: 2010-04-09
Abstract: An apparatus for preparation of a resin impregnated cured in place liner with an integral inner impermeable layer is provided. The liner is formed from a resin impregnable material having an impermeable layer bonded to one surface. The material is formed into tubular shape with the impermeable layer on the outside of the tube about a tubular forming member and continuously everted into the tubular forming device to place the impermeable layer on the inside. An outer impermeable film is placed about the inner tubular layer and may be impregnated with vacuum in the usual manner. Alternatively, the tubular resin impregnable material may be passed through a resin tank and impregnated with a curable resin prior to being wrapped with an outer impermeable layer. The impregnated liner is then suitable for pull-in-and-inflate which can be by steam in view of the integral inner impermeable layer of the liner.
Patent HR-P20110573-T1 (HR)
Inventor: SALMON DIRK
IPC: A47L13/20
Filed: 2011-08-02
Abstract: Uporaba strukturiranog višeslojnog netkanog materijala pogodnog za čišćenje površina za mokro čišćenje površina, pri čemu netkani materijal za čišćenje površina sadrži barem dva tipa vlaknastih sastavnica netkane strukture (1, 2) koji se razlikuju barem što se tiče njihovih sastava materijala, dok su dijelovi vlakana načinjeni od prve vlaknaste sastavnice netkane strukture (1) namješteni u principu vertikalno od površine netkanog materijala za čišćenje površina i oblikuju prvu komponentu od hrpe vlakana (3), a dijelovi vlakana načinjeni od druge vlaknaste sastavnice netkane strukture (2) su isto tako namješteni bitno vertikalno od iste površine i oblikuju drugu komponentu od hrpe vlakana (4), naznačena time, da je prva komponenta od hrpe vlakana (3) stvorena od dijelova vlakana koji apsorbiraju prljavštinu i koji pozitivno utječu na karakteristike kod klizanja, dok je druga komponenta od hrpe vlakana (4) stvorena od dijelova slojeva u hrpi za čuvanje vlage. Patent sadrži još 13 patentnih zahtjeva.
Patent HR-P20160095-T1 (HR)
Title: Anthranilamides, process for the production thereof and pest controllers containing the same
Inventor: KOYANAGI TORI
IPC: C07D401/04
Filed: 2016-01-28
Abstract: To provide a novel anthranilamide compound or its salt which is useful as a pesticide; a process for its production; and a pesticide containing such a compound as an active ingredient.  An anthranilamide compound represented by the formula (I) or its salt. In the formula, R 1  is halogen, alkyl, haloalkyl, etc.; each of R 2  and R 3  which are independent of each other, is halogen, alkyl, haloalkyl, etc.; A is alkyl substituted by Y; Y is C 3-4  cycloalkyl which may be substituted by at least one substituent selected from the group consisting of halogen, alkyl and haloalkyl; m is from 0 to 4; n is 0 or 1; and q is from 0 to 4.
Patent SI-1333747-T1 (SI)
Title: Telescopic extension for an electric household appliance
Inventor: CANALE GIUSEPPE
IPC: A47L9/00
Filed: 2001-10-23
Abstract: A telescopic extension ( 1 ) comprises an inner tube ( 2 ), an outer tube ( 3 ) and a sleeve ( 4 ) in which a constraining element ( 21 ) and a thrust slider ( 30 ) are movably supported; the constraining element ( 21 ) is capable of making integral the inner tube ( 2 ) and the outer tube ( 3 ) and the thrust slider ( 30 ) is connected to an actuating element ( 40 ) and is engaged with the constraining element ( 21 ) under the action of a spring ( 31 ); the constraining element ( 21 ) consists of a projection of an elastic tongue ( 16 ) having one end ( 19 ) formed as one piece with the sleeve ( 4 ).
Patent SI-1392691-T1 (SI)
Title: ANTIFUNGAL 4-SUBSTITUTED 5,6-DIHYDRO-4H-PYRROLO?á1,2-A?å ?á1,4?å BENZODIAZEPINES
Inventor: GILKERSON TERENCE
IPC: A61K31/00
Filed: 2001-10-17
Abstract: The present invention concerns compounds for use as a medicine having the formula the N-oxide forms, the salts, the quaternary amines and stereochemically isomeric forms thereof, wherein R1 represents hydrogen, C1-6alkyl, C1-4alkylthio, C1-4alkyloxy, or halo; R2 represents hydrogen or C1-6alkyl; R3 represents phenyl substituted with halo, cyano, C1-4alkyloxy, C1-4alkylthio, C1-6alkyl, haloC1-6alkyl; 2-thienyl; or 3-thienyl, R4 represents hydrogen; or R2 and R4 form an extra bond, which are active against dermatophytes, and their preparation; it further relates to compositions comprising them, as well as their use as a medicine.
Patent SI-1426123-T1 (SI)
Title: Method and device for internal high pressure forming
Inventor: BIRKERT ARNDT DR-ING
IPC: B21D26/045
Filed: 2003-11-06
Abstract: The sealing die, for use when shaping a profile by inner high pressure, is for a profile with a main contour (1) of one or more walls (2,3,7) extending inwards or outwards or chambers (4-6) pressed radially in front of the profile. The die seals the profile only at the main outer contour. The chamber walls have slits with a depth of at most1 cm to take extensions of the inner and/or outer contour of the profile.
Patent SI-1908461-T1 (SI)
Title: Use of (1S, 2R) enantiomer of milnacipran for the preparation of a medicine
Inventor: DEREGNAUCOURT JEAN
IPC: A61K31/167
Filed: 2004-02-16
Abstract: The use of a mixture of enantiomers of Milnacipran and/or its metabolites or salts, enriched in the dextrorotatory enantiomer F2695, is claimed in medicines for treating pathological disorders treated by the double inhibition of serotonin and noradrenaline recapture, while limiting the risk of cardiovascular disturbance. ACTIVITY : Antidepressant; Muscular-Gen; Immunomodulator; Analgesic; Antiinflammatory; Uropathic; Antiaddictive. MECHANISM OF ACTION : Serotonin inhibitor; Noradrenaline recapture inhibitor. In tests used to determine the capture of noradrenaline and serotonin and the binding of paroxetine in rats, results showed that F2695 was twice as active as the racemic mixture (F2207) and 25 times as active as the levorotatory enantiomer (F2696) in the capture of noradrenaline, that F2695 was three times as active as F2207 and 12 times as active as F2696 in the capture of serotonin and that F2695 was twice as active as F2207 and 10 times as active as F2696 in binding paroxetine.
Patent SI-1735667-T1 (SI)
Title: Radio-controlled wristwatch with means for decoding signals from time signal transmitters from a number of time zones
Inventor: RUDOLPH HOLGER
IPC: H03J5/02
Filed: 2005-01-18
Abstract: The radio-controlled wristwatch comprises a memory unit ( 30 ) in which a table of more than four time signal transmitters ( 1 . . . 10 ) from more than two time zones (A . . . N) is stored. Attempts for receiving from the transmitters ( 1 . . . 10 ) filed in the table are made by a control device ( 28 ), and upon a successful reception of a time signal transmitter ( 1 . . . 10 ) from the table, the appurtenant time is displayed upon the display ( 32 ) of the wristwatch ( 20 ).
Patent SI-2229949-T1 (SI)
Title: Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation
Inventor: MOLLSTAM BO
IPC: A61K35/74
Filed: 2005-06-14
Abstract: The invention herein relates to the use of nonpathogenic, antiinflammatory and anti-bleeding lactic acid bacteria strains, and products and methods using such strains for treatment and prophylaxis of bleeding gum and gingivitis caused by oral inflammation.
Patent SI-1943211-T1 (SI)
Title: Process for preparing substituted dimethyl(3-arylbutyl)amine compounds by means of homogeneous catalysis
Inventor: HELL WOLFGANG
IPC: C07C213/00
Filed: 2006-10-30
Abstract: Compounds of the formula II can be hydrogenated to the corresponding butane derivatives in the presence of homogeneous cataslysts composed of metal salts or complexes containing metals selected from the group consisting of Rh, Ir, and Ru and preferably containing diphosphine ligands, with, in addition, excellent optical yields being achieved when one of R2 and R3 is not a hydrogen atom and the diphosphine ligand is chiral.
Patent SI-2081571-T1 (SI)
Title: Mixed orl 1/ agonists for treating pain
Inventor: LINZ KLAUS
IPC: A61K31/438
Filed: 2007-09-26
Abstract: Use of compounds (I), which exhibit an affinity for the mu -opioid-receptor of at least 100 nM (K i value for human) and an affinity for opioid receptor-like (ORL)-1-receptor, is claimed, where the ratio of the affinities ORL1/mu defined as 1/[K i(ORL1)/K i(mu )] is 1:10 to 30:1, for the production of a medicament and to treat: diabetic neuropathy; narcosis or analgesia during narcosis; pain in patients over 60 years and in patients with increased addictive potential and postoperative pain. An independent claim is included for use of a mu -agonist (II), which is selective as an ORL1/mu defined as 1/[K i(ORL1)/K i(mu )] 1:10, and a ORL1-agonist, which is selective as ORL1/mu defined as 1/[K i(ORL1)/K i(mu )] in a ratio of 30:1 in a mixture, which exhibits the characteristics of the compounds, for the manufacture of medicaments to treat pain. ACTIVITY : Neuroprotective; Analgesic. MECHANISM OF ACTION : Opioid receptor-like-1/mu -agonist.
Patent SI-2254738-T1 (SI)
Title: Method and device for mounting forms
Inventor: BAHLKE STEFAN
IPC: B29C33/00
Filed: 2009-03-04
Abstract: The method and the device are used for mounting forms of a heating process of tires that are produced from an elastomeric material. Form segments of the form are held detachably by a support device. Mounting pins of a guiding element supporting the form segments, said pins being provided with a mounting profile, are guided through an insertion recess of a fixation element disposed in the region of the support device. Thereafter, a locking element of the fixation element is positioned transversely to the longitudinal direction of the mounting pin and thereby locked by the mounting profile with respect to the fixation element. Before carrying out the transversal positioning of the locking element, a tensioning element, which adjusts the fixation element in a longitudinal direction of the mounting pin, is displaced against a spring force. Thereafter, the tensioning element is reset by the spring force in order to hold the mounting profile of the mounting pin in the region of the fixation element by positive fit.
Patent TR-200301134-T1 (TR)
Inventor: GESTEL WILHELMUS J VAN
IPC: G11B20/12
Filed: 2000-07-12
Abstract: The invention relates to recording of information, in particular a real-time audio and/or video signal, in a recording track ( 3 ) of a recording medium ( 2 ) divided into blocks ( 45 ). The recording medium contains a defect list (BS) of addresses of blocks ( 45 *) which are known to be defective. This list is read and during the recording process the defective blocks are skipped. The recording process is performed without any read-after-write check so as to speed up the process. The defect list is updated by noting, during playback, which blocks give rise to reading problems and by including the addresses of these blocks in the defect list on the recording medium.
Patent DE-3687254-T2 (DE)
Inventor: DOVE GEORGE B
IPC: A61K38/55
Filed: 1986-09-01
Granted: 1993-04-15
Abstract: There is disclosed an improved method for separating and recovering proteins, particularly therapeutically active proteins, from an aqueous system also containing a component having the ability to create two liquid phases by use of salt partitioning technology. By the addition of water soluble inorganic salts to an aqueous system containing one or more therapeutically active proteins or nucleic acids, especially an aqueous system obtained from fractionation of a blood plasma fraction or from a tissue culture fluid resulting from a biotechnology production operation such as recombinant DNA and monoclonal antibody technologies, the aqueous system may be separated into two or more liquid phases. Such separated phases may be selectively enriched in components of the original aqueous system having differing solubility in the so-separated liquid phases: